Neuralink, the brain-chip company founded by Elon Musk, is seeking to evaluate its device in a clinical trial. The study, which is anticipated to conclude in 2031, aims to test the implant’s potential to enable paralyzed patients to operate digital devices using their thoughts, Reuters reported.
